Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.